|
Volumn 33, Issue 4, 2002, Pages 331-345
|
International Workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy-related myelodysplastic syndromes and acute leukemia: Overview report
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALKYLATING AGENT;
ANTHRACYCLINE ANTIBIOTIC AGENT;
ACUTE LEUKEMIA;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CHROMOSOME 11Q;
CHROMOSOME 21Q;
CHROMOSOME ABERRATION;
CHROMOSOME ANALYSIS;
CLINICAL FEATURE;
CONFERENCE PAPER;
DEMOGRAPHY;
FOLLOW UP;
HUMAN;
KARYOTYPING;
LATENT PERIOD;
MAJOR CLINICAL STUDY;
MYELODYSPLASTIC SYNDROME;
PREDICTION;
PRIORITY JOURNAL;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS;
CHILD;
CHILD, PRESCHOOL;
CHROMOSOME ABERRATIONS;
FEMALE;
HUMANS;
INFANT;
LEUKEMIA, MYELOCYTIC, ACUTE;
MALE;
MIDDLE AGED;
MYELODYSPLASTIC SYNDROMES;
|
EID: 0036197483
PISSN: 10452257
EISSN: None
Source Type: Journal
DOI: 10.1002/gcc.10040 Document Type: Article |
Times cited : (160)
|
References (10)
|